Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 7, Number 1—February 2001


Active Bacterial Core Surveillance of the Emerging Infections Program Network

Anne Schuchat*Comments to Author , Tami Hilger*, Elizabeth Zell*, Monica M. Farley†, Arthur Reingold‡, Lee Harrison§, Lewis Lefkowitz¶, Richard Danila**, Karen Stefonek††, Nancy Barrett‡‡, Dale Morse§§, Robert Pinner*, and for the Active Bacterial Core Surveillance Team of the Emerging Infections Program Network
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Georgia Emerging Infection Program (Georgia Department of Human Resources, Division of Public Health, Emory University School of Medicine, and the Atlanta Veterans Administration Medical Center) Atlanta, Georgia, USA; ‡California Department of Health Services and UC Berkeley School of Public Health, Berkeley, California, USA; §Maryland Department of Health and Mental Hygiene and Johns Hopkins University School of Public Health, Baltimore, Maryland, USA; ¶Tennessee Department of Health and Vanderbilt University Medical Center, Nashville, Tennessee, USA; **Minnesota Department of Health, St. Paul, Minnesota, USA; ††Oregon Department of Human Resources, Portland, Oregon, USA; ‡‡Connecticut Department of Public Health, Hartford, Connecticut, USA; §§New York State Department of Health, Albany, New York, USA

Main Article

Table 1

Laboratory characterization of isolates collected as part of the Active Bacterial Core surveillance program

Pathogen Test(s)
Group A Streptococcus emm- and T-typing for all invasive isolates; antimicrobial susceptibility testing of periodic samples
Group B Streptococcus Serotyping and antimicrobial susceptibility testing of isolates for selected surveillance areas
Haemophilus influenzae Serotyping of all isolates (a-f); molecular subtyping of isolates as part of special projects
Neisseria meningitidis Molecular subtyping of isolates in conjunction with vaccine development; antimicrobial resistance on isolates periodically
Streptococcus pneumoniae Antimicrobial susceptibility testing for all invasive isolates; serotyping on all invasive isolates since January 1, 1998; subtyping of a sample of isolates using genotyping methods

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO